Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03030989 · ClinicalTrials.gov registry record · Phase 2
A Double-blind Randomized Placebo Controlled Clinical Trial Evaluating Effect of Chlorhexidine Gluconate 2% Cloth vs Placebo Cloth Baths on the Incidence of Central Line-Associated Blood Stream Infections in Outpatient Hematopoietic Stem Cell Transplant Patients
A Phase 2 study of Stem Cell Transplant Complications, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03030989: Completed Phase 2 study of Stem Cell Transplant Complications, sponsored by University of Chicago.
NCT03030989 is a Phase 2 study of Stem Cell Transplant Complications that has completed, run by University of Chicago. The registered enrollment target is 50 participants, below the 182-participant average among 15 other Stem Cell Transplant Complications trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03030989, a Phase 2 study of Stem Cell Transplant Complications, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the use of 2% CHG washcloths in an outpatient setting for adults after hematopoietic stem cell transplant in prevention of central line associated blood stream infections. Half of the participants will use 2% CHG washcloths and other half will use placebo washcloths.
Primary Outcome
Blood stream infections are defined by the presence of bacteria in the blood
Conditions Studied
Interventions
- DRUG Chlorhexidine Gluconate 2% Wipe
- DRUG Placebo Wipe
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-01 |
| Est. Completion | 2019-06 |
| Phase | Phase 2 |
What the finished NCT03030989 record still lists
NCT03030989 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 182-participant average among 15 other Stem Cell Transplant Complications trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Stem Cell Transplant Complications appearing as the primary indexed condition, and to 2 interventions - of which Chlorhexidine Gluconate 2% Wipe is the first listed.
NCT03030989 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03030989 about?
NCT03030989 is a clinical study titled "A Double-blind Randomized Placebo Controlled Clinical Trial Evaluating Effect of Chlorhexidine Gluconate 2% Cloth vs Placebo Cloth Baths on the Incidence of Central Line-Associated Blood Stream Infections in Outpatient Hematopoietic Stem Cell Transplant Patients". This study evaluates the use of 2% CHG washcloths in an outpatient setting for adults after hematopoietic stem cell transplant in prevention of central line associated blood stream infections. Half of the participants will use 2% CHG washcloths and other half will use placebo washcloths.
What is the current status of trial NCT03030989?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2017-01. Estimated completion is 2019-06.
What conditions does trial NCT03030989 study?
This clinical trial studies the following conditions: Stem Cell Transplant Complications.
What interventions are being tested in trial NCT03030989?
The interventions under investigation include: Chlorhexidine Gluconate 2% Wipe (DRUG), Placebo Wipe (DRUG).
Who is sponsoring clinical trial NCT03030989?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03030989 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stem Cell Transplant Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03030989's enrollment target sits among peer trials
50 9th of 15 higher than 6 of 15 other Stem Cell Transplant Complications trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stem Cell Transplant Complications trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
RECRUITING · Phase 2
-
Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant
COMPLETED · Phase 2
-
A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors
RECRUITING · NA
-
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
RECRUITING · NA
-
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
RECRUITING · Phase 3
-
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia